Cargando…
A critical analysis of the review on antimicrobial resistance report and the infectious disease financing facility
Over the past year, two major policy initiatives have been introduced focusing on stimulating antibiotic development for human consumption. The European Investment Bank has announced the development of the Infectious Disease Financing Facility (IDFF) and the British government commissioned the Revie...
Autores principales: | Brogan, David M., Mossialos, Elias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802890/ https://www.ncbi.nlm.nih.gov/pubmed/27000847 http://dx.doi.org/10.1186/s12992-016-0147-y |
Ejemplares similares
-
A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics
por: Renwick, Matthew J, et al.
Publicado: (2016) -
The Global Financing Facility at five: time for a change?
por: Seidelmann, Lisa, et al.
Publicado: (2020) -
Operationalising the Global Financing Facility (GFF) model: the devil is in the detail
por: Salisbury, Nicole A, et al.
Publicado: (2019) -
Incentives for new antibiotics: the Options Market for Antibiotics (OMA) model
por: Brogan, David M, et al.
Publicado: (2013) -
Time to strengthen capacity in infectious disease control at the European level
por: Anderson, Michael, et al.
Publicado: (2020)